Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    19996339 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Efficacy and Safety of 28 or 56 Day Treatment for Pseudomonas Aeruginosa in Children With Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention: Drug: Tobramycin solution for inhalation 300 mg

Indicates status has not been verified in more than two years